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Abstract 
In the present study, the chemical constituents of a medicinal plant, 
Zanthoxylum acanthopodium, were studied. The plant materials were extracted and 
purified by a series of chromatographic separation. Each isolated compound was 
fully characterized by spectroscopic data including one-dimensional and 
two-dimensional nuclear magnetic resonance spectroscopy (^H-NMR, '^C-NMR, and 
DEPT), mass spectrometry (EI-MS, FAB-MS, CI-MS), infrared and ultraviolet 
spectroscopy, as well as physical data, such as melting point, optical rotation. 
The investigation of an ethanol extract prepared from the leaves and stem bark 
of Zanthoxylum acanthopodium led to the isolation of thirteen organic chemical 
compounds. The structures of these chemical ingredients were found to belong to 
different classes, including lignans [(-)-sesamin, (-)-epieudesmin, methyl pluviatilol, 
(+)-methyl piperitol, and (+)-syringaresinol], steroids [p-sitosterol, 
p-sitosterol-P-D-glucoside (daucosterol), and daucosterol 6'-stearate], saponins 
[collettiside III and gracilline], triterpenoid [p-amyrin], and alkanols [1-octacosanol 
and methyl hexacosaiioate]. Several of these identified compounds, e.g. collettiside 
III, gracilline, P-sitosterol-p-D-glucoside and (+)-syringaresinol, are reported for the 
first time from Z acanthopodium. 
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1.1 Studies of Plant Constituents 
N e w drugs can be discovered from two main sources, natural products and 
synthetic chemicals. The synthetic approach has been proven effective in refining 
structural leads that interact with a particular target, while the natural products 
provide a novel of chemical structures for biological testing. 
Human and plants have been in close relation throughout the development of 
civilization. With the archaeological evidence, it is believed that extracts of various 
plants were used as drugs in ancient time.卩,2] Many useful drugs are derived from 
plants, such as morphine, which is the strongest painkiller, derived from opium 
poppy {Papaver somniferum). A series of anticancer drugs also originate from 
plants, for instance, taxol was discovered from the bark of Taxus brevifoliusP� 
Traditional Chinese Medicines (TCMs) are widely used as health foods and 
medicinal substances in China and in many other countries. Some of them have 
scientifically proved to be effective in treating diseases. Notwithstanding the great 
interests in T C M s as a form of complementary and alternative medicine in many 
places, the chemical composition of most T C M s remains unclear. Studies on the 
chemical composition of the medicinal plants can offer plenty of information about 
its ingredients and contribute to the discovery of potential pharmaceutical products. 
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1.2 Extraction of Chemical Ingredients 
The efficiency of extraction of chemical ingredients from plant tissues depends 
on the texture of the plant material being extracted as well as the properties of 
substances contained in it. For example, diosgenin from Dioscorea can be extracted 
after acid hydrolysis of the plant material followed by re-crystallization. For the 
extraction of total ingredients from the plant materials, 95% ethanol is usually used 
as the solvent, because of high solubility and strong puncture ability to plant tissues. 
For plant tissues that contain high contents of oil, such as plant seeds, hexane or 
petroleum ether is often used to defat before extraction. 
For preliminary separation of organic constituents present in the ethanol extract, 
a range of solvents of different polarities (from non-polar to polar) are often used to 
further separate ingredients from the mixture, starting with hexane (for lipids), to 
chloroform (for non-polar compounds), ethyl acetate (for intermediate polar 
compounds) and then butanol (for polar compounds). 
1.3 Separation and Purification of Chemical Ingredients 
Natural products have played, and most likely continue to play, a significant 
role ill drug therapy. In recent years, interests are growing all over the world to 
search for lead compounds from botanical source, either in the form of pure chemical 
entity or mixture of plant constituents. Therefore the use of different kinds of 
separation techniques is necessary for the isolation of pure substances for structural 
studies and bioassays. 
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Among the various methods to separate and isolate plant ingredients, the most 
powerful technique is chromatographic separation. During the procedures of 
separation and purification, Thin Layer Chromatography (TLC) and Open Column 
Chromatography (OCC) are most frequently used. In this project, macro-reticular 
resinous adsorption chromatography was also used. 
1.3.1 Thin Layer Chromatography ( T L C ) 
Thin-layer chromatography has been used for the analysis and separation of 
organic mixtures, such as amino acids, fatty acids, phenols, mineral oils, glycerides, 
and steroids. The technique has many advantages: speed of development (usually 
around 5-20 minutes); the possibility of using drastic reagent (such as concentrated 
sulphuric acid for visualization); simplicity of operation (separation can be 
conducted by using a plate and a glass chamber containing solvent). Versatility is 
also a special advantage of TLC because a number of different adsorbents, such as 
normal-phase and C-18 reverse-phase silica gel, aluminium oxide and polyamide, 
may be spread on aluminium and plastic sheets, or a glass plate. Moreover, it can 
be used for rapid determination of solvents and adsorbents most appropriate for 
column separation.[4’'*^】 
In practice, TLC is used for analytical and preparative purposes. The 
preparative TLC (PTLC) makes use of thick layers of silica gel (0.5 to 1 m m ) 
whereas analytical TLC is achieved by thin layers (0.10 - 0.25 m m ) of adsorbent. 
o 
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1.3.2 O p e n C o l u m n Chromatography ( O C C ) 
Classical Open Column Chromatography is often used to fractionate the crude 
extracts. A number of substances can be used as the adsorbing materials for open 
columns, such as silica gel, Cis bonded reverse phase silica gel, and aluminium oxide 
(separation achieved by adsorption ability), Sephadex gel filtration (separation 
achieved by size difference of molecules), ion exchange resin (separation achieved 
by ion exchange), and marco-reticular resins (separation achieved by adsorption 
ability such as Van der Waals, forces and hydrogen bonding for polar compounds). 
1.4 Methods of Structural Identification 
Many years ago, the structural elucidation of organic compounds was typically 
carried out by classical manipulations involving sodium fusion, solubility test, 
functional group test, derivative preparation, combustion analysis and degradation 
reaction, etc. In many instances, the small amounts of pure compounds isolated 
from complex mixtures would present a challenge to the chemists. With the 
advancement of techniques that are rapid and effective for analyzing milligram and 
microgram quantities, the structures of many natural products can be determined by a 
combination of spectroscopic techniques such as CD, IR, UV, N M R , M S and ESR, 
as well as X-ray crystallography if crystal is obtained. Throughout these years, 
large amount of spectroscopic data, correlating spectral properties with structure, 
were collected and built as databases. These data are useful for structural 
elucidation, thus enabling us to solve structural problems with much less quantity of 
material than the past. 
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1.4.1 Nuclear Magnetic Resonance ( N M R ) 
N M R spectroscopy is a powerful technique for structural elucidation. The 
non-destructive property of this method makes it popular. The power of this 
technique lies in that it not only defines the numbers and types of nuclei present in a 
molecule, but also describes their individual chemical environments, and more 
importantly, the connectivity of nuclei in a molecule. In the process of structure 
determination, 'H-NMR, '^C-NMR, DEPT, 'H, 'H-C0SY, 'H, '^C-COSY, DIFNOE 
and N O E S Y techniques are frequently employed. 
1.4.1.1 Proton N M R Spectroscopy (^H-NMR) 
Most of the structural studies start with 'H-NMR experiment, and the 
application of 'H-NMR spectroscopy for initial identification of structural class is 
convenient and reliable. However, due to the overlapping of proton signals, the 
'H-NMR spectrum alone may not be useful in determining the complete chemical 
structure. 
1.4.1.2 Carbon-13 N M R Spectroscopy (^^C N M R ) 
The '^C-NMR spectra are often recorded by the proton decoupling method, 
displaying carbon signals as single lines. The spectrum therefore provides 
information of the number of carbons present in the molecule. In a proton 
decoupled '^C-NMR spectra, carbon signals are usually well resolved and different 
substituted carbon atoms give signals in a specific shift region. 
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1.4.1.3 Distortionless Enhancement by Polarization Transfer (DEPT) 
Experiment 
A DEPT experiment involves magnetization transfer from an abundant nucleus 
1 1 o 
(typically H) to a rare nucleus (e.g., C). It has been used for spectral editing of 
'^C-NMR spectra. In order to achieve the spectral editing, it relies on the variation 
of the nutation angle ( tt /2, n /4 and 3 n /4). For a specific nutation angle, the 
methyl, methylene, methine and quaternary carbon signals can be distinguished. 
In the DEPT-45 spectrum, all protonated carbons appear as positive singlets, 
while ill DEPT-90 spectrum, only methine carbons can be seen. On the other hand, 
the DEPT-135 spectrum shows methyl and methine carbons signals positively 
(upward signals) and methylene carbons signals negatively (downward signals). 
1.4.1.4 Two-dimensional Homonuclear Correlation Experiment 
The simplest form of homonuclear Correlated Spectroscopy, COSY, was the 
first conceived 2D N M R experiment. Typically, a 2D-C0SY experiment is used to 
provide a map of 'H-'H coupling network in a molecule. It gives rise to an N M R 
spectrum in which ^H chemical shifts along both frequency axes are correlated with 
each other. 
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1.4.1.5 Two-dimensional Heternuclear Chemical shift Correlation 
Experiment 
All H E T C O R (HETeronuclear chemical shift CORrelation) spectrum, also 
known as 'H, '^C-COSY and H M Q C , correlates the signals of a ^ H-NMR spectrum 
with the signals of the '^C-NMR spectrum. It shows the specific proton signals that 
directly attach to particular carbon atoms in the molecules. 
1.4.2 M a s s Spectroscopy 
Mass spectrometry (MS) is a powerful analytical technique useful for the 
identification of compounds and determination of structures. In this technique, 
molecules are ionized and analyzed according to their mass-to-charge ratio. The 
value of this technique lies in the fact that it requires only very small amount of 
sample. It provides information such as molecular weight and the fragmentation 
pattern of the molecule. 
The methods commonly used to produce ions include electron impact (EI), 
chemical ionization (CI), fast atomic bombardment (FAB), and electron spray 
ionization (ESI). 
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1.5 Literature Review 
1.5.1 Medical information on the genus Zanthoxylum 
Zanthoxylum plants are members of the Rutaceae family. Two hundred and 
fifty Zanthoxylum species were found all over the world and about 45 grow in China. 
Many plants of the genus Zanthoxylum are used as food flavoring in China. Some 
of them have medicinal applications, such as treatment of rheumatism, insecticide, 
and abdominal pain owing to roundworm. The medicinal plants of this genus 
include Zanthoxylum acanthopodium, Zanthoxylum ailanthoides, Zanthoxylum 
armatuin, Zanthoxylum avicennae, Zanthoxylum bungeanum, Zanthoxylum 
dimorphophyll um, Zanthoxylum dissitum, Zanthoxylum hamiltonianum and 
Zanthoxylum nitidum. 
For Zanthoxylum acanthopodium, the root part is used in traditional Chinese 
medicine to treat stomachache and rheumatism arthritis 
1.5.2 Compounds found in the genus Zanthoxylum 
Coumarins[i6-i8] and alkaloids^ ^^ ' i9-22] h^ve been found in many species of 
Zanthoxylum. Table 1.1 lists the compounds reported in Zanthoxylum plant. 
Lignans''^ '" 23-241 have been reported in Z acanthopodium, Z armatum, 
Z ailanthoides and Z. nitidum. 
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Flavonoids[i9, 23, 2.^-26] were isolated from Z ailanthoides, Z annatum, 
Z avicennae and Z. bungeanum. Steroids such as /5 -sitosterol and /3 -daucosterol 
are also isolated from Z armatum, Z dissitum, Z ailanthoides and Z. bungeanum. 
1.5.3 Compounds found in Zanthoxylum acanthopodium 
From Zanthoxylum acanthopodium, a number of organic compounds have been 
isolated. Most of these constituents belong to the four main group listed above. 
Table 1.2 shows the chemical compounds reported from Zanthoxylum 
acanthopodium. 
1.5.4 Biological activities of the genus Zanthoxylum 
Some Zanthoxylum plants have been shown to display antibiotic, antifungal 
and anti-inflammatory activities as summarized in Table 1.3. 
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Table 1.1 
Compounds found in Zanthoxylum plants 
Name of plant Coumarin Constituent Ref. 
Z ailanthoides Aurapten 16 
Luvangetin 
Skimmetine 
Z dimorphophyllum Dimoxylin 17 
Scoparone 
Z nitidum 6,7,8-Trimethoxycoumarin 18 
N a m e of plant Alkaloid Constituent Ref. 
Z alicmthoides 6-Oxynitidine 16 
0-methyldecarine 
Z avicennae Dihydroavicine 19 
Nitidine 
Z hungeanum 11 -Methoxychelerythrine 20 
Arnottianamide 
Z dissitum y-Fagarine 21 
Haplopine 




N a m e of plant Lignan Constituent Ref. 




Z. armatum (士)-Asarinin 23 
Fargesin 
(-)-Sesamin 
Z nitidum 1-Asariniii 24 
(-)-Episyringaresinol 
N a m e of plant Flavonoid Constituent Ref. 
Z ailanthoides Hesperidin 25 
Naringin 
Z armatum Nevadensin 23 
Z avicennae Hesperitin 7-mtinosid 19 







Compounds found in Zanthoxylum acanthopodium 
Compound reported Class Ref 
Acanthotoxin Lignan 11 
Aesculetiii dimethylether Coumarin 8 
Acetonyldihydrochelerythrine Alkaloid 8 
-Amyrenone Pentacyclic triterpene 14 
(3 -Amyrin Pentacyclic triterpene 14 
1 -Asarinin Lignan 8 
Dictamnine Alkaloid 6 
(±)-Eduesmiii Lignan 12 
(+)-Epieudesmin Lignan 13 
(+)-Episesamin Lignan 13 
Fargesin Lignan 12 
5-(3-Hydroxypropyl)-7-methoxybenzofuran Beiizofuran 7 
Methoxydictamnine Alkaloid 6 
(±)-Methyl piperitol Lignan 13 
Methyl pluviatilol Lignan 13 
Platydesmine Alkaloid 6 
(-)-Piperitol Lignan 6 
Piperitol- 丁 , j -dimethylallylether Lignan 8 
(-)-Pluviatilol Lignan 6 
Pluviatilol- 7', j -dimethylallylether Lignan 8 
12 
Podotoxin Lignan 9 
Sesamin Lignan 6 
/3 -Sitosterol Sterol 8 
Skimmianine Alkaloid 6 
Tambulin Flavonoid 15 














































































































































































































































































































































































































































































































































































































































































































































































































































1.6 Research plan and Objectives of the present study 
In the present study, the leaves and stem bark of Chinese medicinal plant, 
(shown in figure 1.1) Zanthoxylum acanthopodium D.C. (Fam. Rutaceae) were 
investigated. 
Fig. 1.1 The leaves and stem bark ^ ^ ^ m ^ M ' ^ f f l K ^ ^ ^ J ^ ^ 
of Zanthoxylum acanthopodium J f ^ ^ ^ B ^ j i S 
ImM^m 
The plant materials were collected by Dr. Hui Yang in Yannan and properly 
identified by plant taxonomist at the Kunming Institute of Botany, Chinese Academy 
of Sciences, in which voucher specimens were deposited (voucher number: KIB 
01-5-23 Tao). 
The present study started with a comprehensive search of literature for 
pharmacological and chemical information concerning the plant species and the 
genus as a whole. According to the literature, the root part of Z. acanthopodium is 
used in traditional Chinese medicine as stomach-ache, birth control and rheumatoid 
arthritis.[6-8] Two structural classes of compounds, lignans and pentacyclic 
triterpenoids, have been found in the stem bark of Z acanthopodium 
The present work was carried out in an attempt to isolate, identify and 
determine the structures of the chemical constituents of the leaves and stem bark of 
the plant, using various separation and spectroscopic techniques. 
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Chapter 2 
Materials & Methods 
2.1 General experimental procedures 
2.1.1 Solvents 
A R grade acetone, chloroform, diethyl ether, ethyl acetate, methanol, deionized 
water and technical grade hexane with prior distillation, were used for column 
chromatographic separations and used as the developing solvent for analytical and 
preparative TLC. 
2.1.2 Chromatographic methods 
2.1.2.1 Normal phase chromatography 
Normal phase adsorption chromatography was performed on columns of silica 
gel 60 (70-230 mesh) and TLC grade (HG/T2354-92, Qingdao Haiyang Chamical 
Co., Ltd.) under pressure by compress air. 
2.1.2.2 Macro-reticular resinous adsorption chromatography 
Macro-reticular resinous adsorption chromatography was performed on columns 
of macro-reticular resin (大?L樹S旨)(DlOl) under normal atmospheric pressure. 
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2.1.2.3 Normal phase preparative thin layer chromatography 
Normal phase preparative thin layer chromatography was performed on Merck 
Silica gel 60 F254+366 plates, thickness 2 m m , 20x20 cm. The plates were visualized 
under U V lamp (with wavelength of 254 iirn or 366 nm) and iodine vapor. 
2.1.2.4 Thin layer chromatography 
Analytical TLC was conducted on Merck Silica gel 60 F254 precoated 
aluminium back plates, thickness 0.2 m m , 20x20 cm. The plates were visualized 
under U V lamp (with wavelength of 254 nm or 366 nm) and iodine vapor. 
2.1.3 Determination of physical data 
2.1.3.1 Melting point determination 
All melting points (m.p.) were determined on an Electrothermal 9100 melting 
point measuring instrument and were uncorrected. 
2.1.3.2 Optical rotation (OR) 
Optical rotation of the isolated compounds was determined on a Perkin Elmer 
341 polarimeter using a NaHal 589 light source and a decimeter microcell. 
Concentration was expressed in gram per 100 milliliters. 
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2.1.3.3 Ultraviolet (UV) absorption spectra 
U V spectra were recorded using a Gary IE UV-visible spectrophotometer. 
Ethanol was used as solvent and quartz cells were used; concentration was expressed 
ill gram per 100 milliliters. 
2.1.3.4 Infra-red (IR) absorption spectra 
IR absorption spectra were recorded using a Perkin Elmer 1600 series FT-IR 
spectrometer. A KBr disc was made for each sample for measuring the IR spectra. 
2.1.3.5 Nuclear magnetic resonance spectra ( N M R ) 
One- and two-dimensional and '^C-NMR spectra were recorded on a Bruker 
A V A N C E DPX300 N M R spectrometer. Tetramethylsilane (TMS) was used as the 
internal standard ( 6 0.00 ppm). Chemical shifts were reported in parts per million 
(ppm) on the 6 scale and J-coupling constants (J) were expressed in Hz. Solvents 
used in N M R experiments included deuterochloroform (CDCb), deuterated methanol 
(CD3OD) and deuterated pyridine (C5D5N). 
2.1.3.6 Mass spectra (MS) 
Mass spectra (CI, FAB, EI) were obtained using a ThermoFinnigan M A T 95 X L 
mass spectrometer (EI mode at 70eV; CI mode, reagent gas: isobutaiie; FAB mode, 




3.1 Procurement, extraction and initial fractionation of dried 
leaves and stem bark of Zanthoxylum acanthopodium 
The leaves and stem bark of Zanthoxylum acanthopodium were collected by Dr. 
Hui Yang from Yunnan and authenticated. Voucher specimen was deposited in the 
Kunming Institute of Botany, Chinese Academy of Sciences, P.R. China (voucher 
number: KIB 01-5-23 Tao). The plant material was finely ground. 
The Z acanthopodium powder (4.2 kg) was soaked in 95 % ethanol and 
refliixed at 78°C three times for four hours each. The pooled extract was dried 
under reduced pressure to afford an extract at a yield of 19 % (w/w). 
The extract (800 g) was dissolved in deionized water with warming in the 
ultrasonic bath, and partitioned with hexane, ethyl acetate and n-butanol successively. 
The three extracts were dried to obtain extractives at a yield of 2.48 % , 2.26 % , 
10.65 % (w/w), respectively. 
The extracts were analyzed by TLC [solvent systems: hexane:chloroform (2:1), 
hexane:ethyl acetate (10:1), hexane:acetone (5:1), chloroform:methanol (1:1), 
detected by concentrated H2SO4 and U V lamp with wavelength 254 nm and/or 
366 nm] for the presence of chemical compounds. It was found that the hexane and 
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ethyl acetate extracts contained similar composition, and therefore these two 
fractions were combined and further purified by chromatographic separation. The 
relatively polar n-butanol extract was fractionated by macro-reticular resin followed 
by silica gel chromatographic separation. 
3.2 Chromatographic separation of the combined hexane and ethyl 
acetate extract 
The combined extract (38 g) was adsorbed on silica gel (70-230 mesh) and 
chromatographed on a silica gel column (760 g, TLC grade, Qingdao) eluted 
successively with hexane, hexane:chloroform (9:1+3:2—1:4), and chloroform to 
afford nineteen fractions (HEA-A-HEA-S). 
3.2.1 Column chromatographic separation of fraction H E A - E 
Fraction HEA-E (3.53 g) was adsorbed on silica gel (70-230 mesh) and 
subjected to chromatography over silica gel (75 g, TLC grade, Qingdao), eluting 
stepwise with hexane:ethyl acetate (20:1, 10:1, 5:1, 2:1) to afford twelve fractions 
(HEA-E 1 一 HEA-E 12). From fraction HEA-E8 (1.31 g), compound 1 (374 mg) 
was obtained by recrystallized in chloroform. 
3.2.1.1 Characterization of ^ -sitosterol 
Compound 1, white amorphous powder (CHCI3), 374 mg, M W 414, C29H50O, 
m p 133.6-135.3。C ; [ a ]D —31.1 (CHCI3); Rr 0.34 (CHCI3); IR (KBr), 
24 
max(cm"'), 3420 br, 2930, 1663, 1459, 1375, 1049; U V (EtOH), ；I,丽(nm) 
(log e ), 201.5 (12.4); EIMS, m/z 414 [M]\ 399, 396, 381, 314, 303, 273, 255, 231, 
213, fragmentation pattern is shown in Fig. 4.2; 'H- and '^C-NMR data are given in 
Table 4.1. 
3.2.2 Column chromatographic separation of fraction H E A - F 
Fraction HEA-F (1.53 g) was adsorbed on silica gel (70-230 mesh) and 
subjected to chromatography over silica gel (35 g, TLC grade, Qingdao), eluting with 
hexane:acetone (20:1, 10:1, 5:1, 1:1) successively to afford nine fractions 
(HEA-F 1 - HEA-F9). Fraction HEA-F5 (296 mg) was adsorbed on silica gel 
(70-230 mesh) and subjected to column chromatography on silica gel (9 g, TLC 
grade, Qingdao) eluted with hexane:ethyl acetate (20:1, 5:1, 1:1) to afford six 
fractions (HEA-F5-A - HEA-F5-F). HEA-F5-A was recombined with HEA-F5-B, 
designated as HEA-F5-A2 (135 mg), from which compound 6 (23 mg) and 12 (15 
mg) were obtained by preparative TLC and developed in chloroform:acetone (50:1). 
From fraction HEA-F8 (185 mg), compound 7 (68 mg) was obtained by preparative 
TLC developed in chloroform:acetone (20:1). 
3.2.2.1 Characterization of ff -amyrin 
Compound 6, white powder (CHCI3), 23 mg, M W 426, C30H50O, 
m p 195.3-198.6t：; [ a h +75 (CeHe); R,- : 0.58 (CHCb-Acetone, 50:1); IR(KBr), 
max(cm''), 3413, 2915, 2861, 1714, 1647, 1458, 1377, 1036; U V (EtOH), 
A,腿(nm) (log £ ), 208 (14.3); F A R M S , m/z 427 [M+H]^ 411, 408, 218, 207, 203, 
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189; 'H-NMR (CD3CI), 5 5.17 (IH, t, J = 3.0 Hz, -CH=C-), (5 3.24 (IH, 
m, -CH2OH), (51.13 - 2.11 (23H, m), 6 0.76 - 1.27 (24H, m, 8-CH3); ''C-NMR 
data are given in Table 4.6. 
3.2.2.2 Characterization of 1-octacosanol 
Compound 12, white powder (CHCI3), 15 mg, M W 410, C28H58O, 
mp 71.5-73.6。C; Rf ： 0.54 (CHCls-Acetone, 50:1); IR(KBr), max(cm"'), 3403 br, 
2926, 1457’ 1377, 1248, 1035; U V (EtOH), ；I,丽(nm) (log e ), 200.5 (13.2); 
EIMS, m/z 410 [M+], 392, 364, 336, 308, 280, 252, 237, 57; 'H-NMR (300 M H z , 
CHCI3). (5 3.57 (2H, t, J = 6.7 Hz, -CH2OH), (51.18- (51.49, (long chain -CH2-), 
(50.81 (3H, t, J = 7.0 Hz, -CH3); '^C-NMR (CHCI3), 6 63.7 (C-1), (5 33.4 (C-2), 
(5 26.3 (C-3), 30.2 (C-4), (5 30.2 (C-5 - C-24), 5 29.9 (C-25), (5 32.5 (C-26), 
(5 23.2 (C-27), (514.7(C-28). 
3.2.2.3 Characterization of (-)-sesamin 
Compound 7，pale yellow amorphous powder (CHCI3), 68 mg, M W 354, 
C 2 OH , 8 0 6 , mp 119.8-121.2°C； [ A ] D -35 (CHCI3); R, ： 0.73 (CHCh-Acetone, 20:1); 
IR(KBr), z^  max(cm"*), 2850, 926, 1607, 1501，1443, 1366, 1251, 1194; U V (EtOH), 
A _ ( n m ) (log e ), 287 (10.1), 236 (12.7), 207.5 (103.0); EIMS, m/z 354 [M+], 135, 
150, 149, 161，151, 123; ^ H- and '^C-NMR data are given in Tables 4.7 and 4.8. 
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3.2.3 Column chromatographic separation of fraction H E A - G 
Fraction HEA-G (2.19 g) was adsorbed on silica gel (70-230 mesh) and 
subjected to chromatography over silica gel (45 g, TLC grade, Qingdao), elutiiig with 
hexane:ethyl acetate (5:1, 3:1, 1:1) successively to afford seven fractions (HEA-G 1 -
HEA-G7). From fraction HEA-G 1 (16 mg), compound 13 was obtained. Fraction 
HEA-G6 (828 mg) was adsorbed on silica gel (70-230 mesh) and subjected to 
column chromatography over silica gel (17 g, TLC grade, Qingdao), eluting with 
hexane:ethyl acetate (5:1, 3:1, 1:1) successively to afford three fractions 
(HEA-G6-A - HEA-G6-C). From fraction HEA-G6-A (75 mg), compound 10 
(35 mg) was obtained by preparative TLC developed in hexane:acetone (1:1). 
3.2.3.1 Characterization of methyl hexacosanoate 
Compound 13, white powder (CHCI3), 16 mg, M W 410, C27H54O2, 
mp 57.9-59.5。C; Rf: 0.59 (Hexane-Acetone, 2:1); IR(KBr),〉max(cm"'), 3424, 2918, 
2851, 1707, 1466, 724; U V (EtOH), ；I,腿(nm) (log £ ), 202 (21.0); EIMS,m/z410, 
[Mf, 383, 369, 355, 299, 271, 154, 124; 'H-NMR (300 M H z , CHCI3), (5 2.34 (2H, t, 
J = 6.7 Hz), (5 1.65 - 1.25, (long chain -CH2-), (5 0.88 (3H, t, J = 6.7 Hz, -CH3); 
''C-NMR (CHCI3), (5 34.4 (C-l，)，5 179.8 (C-1), (5 32.5 (C-2), 5 25.2 (C-3), 
(5 29.6 (C-4), 5 30.0 (C-5), 6 30.2 (C-6 - C-23), (528.9 (C-23), (5 29.8 (C-24), 
(5 23.2 (C-25), 514.7 (C-26). 
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3.2.3.2 Characterization of methyl pluviatilol 
Compound 10, yellow amorphous powder (CHCI3), 35 mg, M W 370, C21H22O6, 
m p 137.1-138.2°C； [ah +78 (CHCI3); Re : 0.40 (Hexane-Acetone, 1:1); IR(KBi-), 
max(cm-'), 3437 br, 2960, 2866, 1599, 1510, 1497, 1447, 1366, 1334, 1245, 1085, 
1033，925, 815; U V (EtOH), ；I,丽(rnn) (log e ), 284.5 (8.0), 242.5 (15.0); EIMS, 
m/z 370 [M+], 177, 167, 166，165, 151, 150, 149, 139, 137, 135, 121, 120, 100; 'H-
and '^C-NMR data are given in Tables 4.7 and 4.8. 
3.2.4 Column chromatographic separation of fraction H E A - H 
Fraction HEA-H (4.27 g) was adsorbed on silica gel (70-230 mesh) and 
subjected to chromatography over silica gel (90 g, TLC grade, Qingdao), eluting with 
hexane: chloroform (1:5, 1:10) successively to afford six fractions 
(HEA-H 1 — HEA-H6). Fraction HEA-H2 (768 nig) was adsorbed on silica gel 
(70-230 mesh) and subjected to column chromatography over silica gel (16 g, TLC 
grade, Qingdao), eluting with hexane:ethyl acetate (3:1, 1:1) to afford eleven 
fractions (HEA-H2-A - HEA-H2-K). Fraction HEA-H3 (1.223 g) was adsorbed on 
silica gel (70-230 mesh) and subjected to column chromatography over silica gel 
(25 g, T L C grade, Qingdao), eluting with hexane:ethyl acetate (3:2, 3:1, 1:1) to 
afford sixteen fractions (HEA-H3-A 一 HEA-H3-P). HEA-H3-G was recombined 
with HEA-H2-D, designated as HEA-H2-D1 (73 mg), and compound 9 (35 mg) was 
obtained by preparative TLC developed in chloroform:acetone (20:1). From 
fraction HEA-H2-H (108 mg), compound 8 (59 mg) was obtained by preparative 
TLC developed in chloroform:acetone (20:1). 
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3.2.4.1 Characterization of (+)-methyI piperitol 
Compound 9，yellow amorphous powder (CHCI3), 56 mg, M W 370, C21H22O6, 
m p 75.6-76.2°C； [ah +61 (CHCI3); Rf : 0.59 (CHCls-Acetone, 20:1); IR(KBr), 
max(cm"'), 3479 br, 2929, 2856, 1593, .1515, 1492, 1444, 1341, 1263, 1249, 1236, 
1140，1033, 930, 810; U V (EtOH), A m a x ( n m ) (log e), 284.5 (6.9), 242.5 (15.3); 
EIMS, m/z 370 [M+], 177, 167, 166, 165, 151, 150, 149, 139, 137, 135, 121, 120, 100; 
'H- and '"C-NMR data are given in Tables 4.7 and 4.8. 
3.2.4.2 Characterization of (-)-epieudesmin 
Compound 8, pale yellow amorphous powder (CHCI3), 59 mg, M W 386, 
C22H26O6, m p 105.3-107.8°C； [a]D -101 (CHCI3); Rf : 0.58 (CHCb-Acetone, 
20:1); IR(KBr), max(cm"'), 2847, 1590, 1513, 1464, 1418, 1375, 1337, 1279, 930, 
1163, 1079, 1039; U V (EtOH), A max(nm) (log £), 202.0 (102.3), 229.0 (19.7), 
275.5 (6.7); EIMS, m/z 386 [M+]，177, 167, 166，165, 161, 151, 139; 'H- and 
'^C-NMR data are given in Tables 4.7 and 4.8. 
3.2.5 Column chromatographic separation of fraction H E A - K 
Fraction H E A - K (1.88 g) was adsorbed on silica gel (70-230 mesh) and 
subjected to chromatography over silica gel (40 g, TLC grade, Qingdao), eluting with 
pure chloroform, chlroroform:methanol (10:1, 20:1) successively to afford nine 
fractions (HEA-Kl - HEA-K9). HEA-K3 (148 mg) was adsorbed on silica gel 
(70-230 mesh) and subjected to column chromatography over silica gel (3 g, TLC 
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grade, Qingdao), eluting with chloroform:acetone (20:1) successively to afford four 
fractions (HEA-K3-A — HEA-K3-D). From fraction HEA-K3-C (75 mg), 
compound 11 (16 mg) was obtained by preparative TLC developed in 
hexane: acetone (1:1) 
3.2.5.1 Characterization of (+)-syringaresinol 
Compound 11, pale yellow amorphous powder (CHCI3), 16 mg, M W 418, 
C22H26O8, mp 174.2-176.8。C; [ah +35 (CHCI3); Rf: 0.26 (Hexane-Acetone, 1:1)； 
IR(KBr), max(cm-'), 3420 br, 2938, 1613, 1517, 1460, 1426, 1324, 1216, 1115,992, 
830; U V (EtOH), Amax(nm) (log e), 274.0 (12.4), 217.0 (98.2); EIMS, m/z 418 
[M+], 401, 281, 265, 199, 182, 171, 167, 154; 'H- and '^C-NMR data are given in 
Tables 4.7 and 4.8. 
3.2.6 Column chromatographic separation of fraction H E A - M 
Fraction H E A - M (3.82 g) was adsorbed on silica gel (70-230 mesh) and 
subjected to chromatography over silica gel (82 g, TLC grade, Qingdao), eluting with 
hexane: acetone (3:1, 1:1) successively to afford nineteen fractions 
(HEA-M 1 - H E A - M 19). Fraction HEA-M9 (530 mg) was adsorbed on silica gel 
(70-230 mesh) and subjected to column chromatography over silica gel (11 g, TLC 
grade, Qingdao), eluting with chloroform:acetone (1:1, 1:3) to afford five fractions 
(HEA-M9-A - HEA-M9-D). Fraction HEA-M9-C (31 mg) was identified as 
compound 3. 
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3.2.6.1 Characterization of daucosterol 6,-stearate 
Compound 3, white amorphous powder (CHCI3), 31 mg, M W 842, C53H94O7’ 
m p 165.8-167.7。C; Rf 0.39 (Hexane-Acetone, 3:2); IR(KBr), v maxCcrn''), 3385 br, 
2920, 2850, 1724, 1643, 1466, 1377，1078, 1024; U V (EtOH), Aniax(nm) (log e ), 
202.5 (13.5); EIMS, m/z 842 [M+], 605, 533，414, 396，255, 135, 120, 85; 'H- and 
'^C-NMR data are given in Table 4.3. 
3.2.7 C o l u m n chromatographic separation of fraction H E A - P 
On concentration, white precipitates (145 mg) were found in fraction HEA-P. 
It was dissolved in hot methanol for further crystallization. Compound 2 was then 
obtained. 
3.2.7.1 Characterization of ^  -sitosterol- fi -D-glucoside (daucosterol) 
Compound 2, white amorphous powder (pyridine), 145 mg, M W 576, C35H6oO(), 
m p 282.1-285.3 °C ； [ a ]D -40.2 (pyridine); R,- 0.59 (CHCb-MeOH, 4:1); 
IR(KBr), ,腿(cm—i), 3413 br, 2932, 2874, 1640, 1457, 1373, 1067, 1024; 
U V (EtOH), A max(nm) (log e )，203.5 (12.0); EIMS, m/z 576 [M]+, 414, 398, 397, 
396, 382, 255, 135, 120, 85; 'H- and '^C-NMR data are given in Table 4.2. 
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3.3 Chromatographic separation of the n-butanol extract 
The n-butanol extract (85.2 g) was dissolved in DI water (1:1) and allowed to 
stand overnight. The precipitates formed were filtered and subjected to column 
chromatography over macro-reticulai* resin (300 g, DlOl) eluted with water, 
water:methanol, (9:1—3:2—1:4) and pure methanol to afford eleven fraction 
(Bu-A-Bu-K). 
3.3.1 C o l u m n chromatographic separation of fraction Bu-I 
Fractions Bu-J was recombined with Bu-I, designated as Bu-I (1.35 g), 
followed by adsorption on silica gel (70-230 mesh) and column chromatography over 
silica gel (30 g, T L C grade, Qingdao), eluting with chloroform:methanol (10:1, 5:1, 
1:1) and pure methanol successively. Seven fractions (Bu-Il - Bu-Ill) were 
obtained. From fraction Bii-I4 (105 mg), compound 4 (32 mg) was purified by 
preparative T L C developed in chloroform:methanol (3:1). From fraction Bu-I6 (68 
mg), compound 5 (23 mg) was purified by preparative T L C developed in 
chloroform:methanol (3:1). 
3.3.1.1 Characterization of collettiside III 
Compound 4, yellow amorphous powder (pyridine), 32 mg, M W 868, 
C45H72O16’ m p 273.2-275.5°C； Rf 0.32 (CHCb-MeOH, 3:1); IR (KBr), v ,丽(cirfi)’ 
3420 br, 2930, 1732, 1636，1453, 1383, 1132, 1047, 982，899, 812, 618; U V (EtOH), 
A nm(nm) (log £ ), 202 (13.2); EIMS, m/z 892 [M+Na+H]+, 869 [M+H]+, 722, 575, 
32 
414, 410; 'H and '^C N M R data are given in Table 4.4. 
3.3.1.2 Characterization of gracilline 
Compound 5, white amorphous powder (pyridine), 23 mg, M W 884，C45H72O17, 
m p 287.9-291.rc； Rf 0.39 (CHCb-MeOH, 3:1); IR (KBr), v maxlcrn''), 3420 br, 
2926, 1732, 1633, 1453, 1383, 1153, 1050, 982, 899, 812, 617; U V (EtOH), 
A,nax(nm) (log £ ), 201.5 (11.2); EIMS, m/z 885 [M+H]+, 738’ 724, 577, 416, 410; 

















































































































































































































































































































































































































































































































4.1 Isolated c o m p o u n d s 
4.1.1 Sterols 
Many naturally occurring substances, such as sterols, bile acids, sex hormones, 
adrenal cortical hormones, cardiac glycosides and toad poisons contain the 
cyclopentanoperhydrophenanthrene ring system or, in very rare cases, a modification 
of it. 
3 
Fig. 4.1 Structure of cyclopentanoperhydrophenanthrene ring 
Sterols are widely distributed in nature. They are found both in the free state 
and combined as esters or glycosides. Very often they occur in the form of complex 
mixtures. Most of the sterols are hydroxylated at C3, while some also have O H 
groups in other positions of the ring system or side chain.⑴ 
From the plant extract of Z. acanthopodium, three plant sterols and derivatives 
(/3 -sitosterol, (3 -sitosterol- /3 -D-glucoside and daucosterol 6丨-stearate) were 
isolated and fully characterized as follows. 
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4.1.1.1 Identification of ^ -sitosterol (1) 
Compound 1 was developed on a TLC plate with chloroform as the developing 
solvent. It showed no spots either under short or long wavelength U V lamp, while a 
single pink spot was observed after spraying with concentrated sulfuric acid and 
heating. By putting the TLC plate into a chamber filled with iodine vapor, a 
yellowish orange spot was observed without spraying or heating. 
The EIMS spectrum displayed a molecular ion peak at m/z 414. Together with 
the '^C-NMR and D E P T spectra, the formula of compound 1 was shown to be 
C29H50O. The presence of a signal at m/z 396 [M-18]+，which corresponds to the 
fragment obtained after elimination of water, suggested that the compound contained 
an O H group. The fragmentation pathway and the structure of fragments are shown 
in Fig. 4.3. 
The IR spectrum indicated the presence of a hydroxyl group (medium strong, 
broad peak at 3420 cm"'). In the 'H-NMR spectrum, a proton signal at d h 3.52, 
together with a peak at 6 c 72.3 showed that the hydroxyl group was a 
secondary O H . Also shown in the "H-NMR spectrum were six tertiary methyl 
signals ((50.68, (^0.81, (5 0.84, (50.87, 50.93 and 5 0.68). 
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The IR spectrum indicated the presence of a C=C double bond (weak peak at 
1663 cm"'). No U V absorption above 235 nm suggested the absence of conjugated 
chromophore. Its 'H-NMR spectrum also showed a proton signal of 
-CH=C- at (5 H 5.34. 
The identity of compounds 1 was established by comparison with reported 
spectral data of /5 -sitosterol.[2-5] 
The N M R results of compound 1 are summarized in Table 4.1 and the structure 





Fig 4.2 Structure of /3 -sitosterol (1) 
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Table 4.1 'H- and '^C-NMR data of /3 -sitosterol (1) 
13c Chemical shift ((5) Multiplicity 'H Chemical shift ((5 ) 
C-1 37.8 CH2 H-1 0.93 m , 1.65 m 
C-2 34.2 CH2 H-2 2.26 m , 1.65 m 
C-3 72.3 C H H-3 3.52 m 
C-4 42.8 CH2 H-4 2.27 m 
C-5 141.3 C - -
C-6 122.3 C H H-6 5.34 m 
C-7 32.4 CH2 H-7 1.65 m, 1.99 m 
C-8 32.2 C H H-8 1.36m 
C-9 51.8 C H H-9 0.84 m 
C-10 37.0 C - -
C-11 21.6 CH2 H-11 1.47m 
C-12 40.3 CH2 H-12 1.99 m , 1.14 m 
C-13 46.4 C - -
C-14 57.3 C H H14 0.94 m 
C-15 24.8 CH2 H-15 1.03 m , 1.51 m 
C-16 28.8 CH2 H-16 1.14 m , 1.82 m 
C-17 56.6 C H H-17 1.14 m 
C-18 12.5 CH3 H-18 0.67 s 
C-19 19.9 CH3 H-19 0.93 s 
C-20 36.7 C H H-20 1.47m 
C-21 19.6 CH3 H-21 1.00 s 
C-22 34.5 CH2 H-22 1.47 m , 1.14 m 
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Table 4.1 (continued) 
C-23 29.7 CH2 H-23 1.47m 
C-24 50.7 C H H-24 1.03 m 
C-25 26.6 C H H-25 1.65 m 
C-26 19.4 CH3 H-26 0.81 s 
C-27 20.4 CH3 H-27 0.84 s 
C-28 23.6 CH2 H-28 1.3 m 
C-29 12.4 CH3 H-29 0.86 s 
T h e ' -^C-NMR assignments agree with those reported in the literature.'"'^' 
T h e unit o f chemical shift is ppm 
m = multiplet; s = singlet 
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Figure 4.3 
Mass spectroscopic study of ^ -sitosterol (1) 
a. Fragmentation pathway 
[M-C7HI6]+ ^ [M-CH/ ^ [M-CHgO]^ 
m/z 314 / m/z 399 m/z 381 
/ j C 下 “ 
y / ^ ^ [M-Hpf • 
/ ^ m/z 396 
/ H O ^ - ^ _ + . m / z 4 1 4 “ 
,。13"27]+ ^ , [M-CioH2I]+ ^ [Ci9H27] + 
m/z 231 m/z 273 m/z 255 
[M-Ci3H29〇]+ [M-C8HI5]+ 
m/z 213 m/z 303 
b. Structure of fragments 
/ / 
m/z 396 m/z 397 
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4.1.1.2 Identification of /5 -sitosterol- 3 -D-glucoside (2) 
Compound 2 was developed on a TLC plate with chloroform:methano 1 (4:1) as 
the developing solvent. It showed no spots either under short or long wavelength 
U V lamp, while a single pink spot was observed after spraying with concentrated 
sulfuric acid and heating. By putting the TLC plate into a chamber filled with 
iodine vapor, a yellowish orange spot was observed without spraying or heating. 
The EIMS spectrum displayed a molecular ion peak at m/z 576. In the EIMS 
spectrum, ion peak at m/z 414, which corresponds to mass of sitosterol, arises by the 
cleavage of carbon-oxygen bond at y and a hydrogen rearrangement. Peak at 
[M-180]+ m/z 396 corresponds to the fragment obtained after the elimination of sugar, 
while the peak at m/z 397 suggested the cleavage of the carbon-oxygen bond at x. 
The structures of the fragments are shown in Fig 4.3 and Fig 4.4. 
Y u X 
Fig. 4.4 Fragmentation pattern of steroid glycoside 
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According to the '^C-NMR and DEPT spectra, an anomeric carbon signal 
(d 102.5) together with hydroxylated carbons at 5 62.7 (CH2), (571.6 (CH), d 
75.2 (CH) and 5 78.3 (CH) were displayed. They are indicative of a 
monosaccharide (glucose) moiety. By comparing with the spectra of compound 1, 
the monosaccharide moiety should be attached to the C-3 of the sterol structure 
((5 78.4). It was also supported by the IR signals at 3413 cm"' (medium strong, 
broad peak) and 1373 cm"' (medium strong, sharp peak) indicating the presence of 
hydroxy 1 group and ether linkage (-0-C0-CH-). 
By comparing with literature values[4-)l, compound 2 was identified to be 
/3 -sitosterol- /3 -D-glucoside. 
The N M R results of compound 2 are summarized in Table 4.2 and the structure 
of compound 2 was shown below, 
Et 
、\H 
H 〇 " | 广々 
H 〇 z 、 A 〇  
H H 
OH 
Fig. 4.5 Structure of (3 -sitosterol- (3 -D-glucoside (2) 
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Table 4.2 丨H- and ''C-NMR data of /3 -sitosterol- /3 -D-glucoside (2) 
Chemical shift ( ) Multiplicity ^H Chemical shift (5) 
C-1 37.4 CH2 H-1 0.98 m , 1.72 m 
C-2 30.2 CH2 H-2 1.75 m , 2.14 m 
C-3 78.4 C H H-3 3.98 m 
C-4 39.2 CH2 H-4 2.49 ddd,J = 2.0, 12.9, 12.9 
2.72 ddd, J = 2.0, 4.7, 12.9 
C-5 140.9 C - _ 
C-6 121.9 C H H-6 5.35 1, J = 2.5 
C-7 32.1 CH2 H-7 1.60 ddd, J = 2.5,7.0, 16.0 
1.95 ddd, J = 2.5, 7.0, 16.0 
C-8 32.0 C H H-8 1.36 m 
C-9 50.3 C H H-9 0.85 m 
C-10 36.9 C - . 
C-11 21.2 CH2 H-11 1.42m 
C-12 39.9 CH2 H-12 1.10 m , 1.98 m 
C-13 42.4 C - . 
C-14 56.8 C H H14 0.95 m 
C-15 24.5 CH2 H-15 1.05 m , 1.57 m 
C-16 28.5 CH2 H-16 1.25 m, 1.85 m 
C-口 56.2 C H H-17 1.10m 
C-18 12.0 CH3 H-18 0.66 S 
C-19 19.4 CH3 H-19 0.94 s 
C-20 36.3 C H H-20 1.40 m 
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Table 4.1 (continued) 
C-21 19.0 CH3 H-21 0.98 d, J = 6.5 
C-22 34.2 CH2 H-22 1.10 m , 1.40 m 
C-23 26.3 CH2 H-23 1.25 m 
C-24 46.0 C H H-24 1.00m 
C-25 29.4 C H H-25 1.68 m 
C-26 19.2 CH3 H-26 0.84 d, J = 7.0 
C-27 20.0 CH3 H-27 0.86 d, J = 7.0 
C-28 23.3 CH2 H-28 1.30 m 
C-29 12.1 CH3 H-29 0.881, J = 7.5 
C-r 102.5 C H H-r 5.04 d, J = 7.7 
C-2’ 75.2 C H H-2' 4.04 dd, J = 7.7,7.5 
C-3' 78.3 C H H-3' 4.271，J = 7.5 
C-4' 71.6 C H H-4' 4.271, J = 7.5 
C-51 78.3 C H H-5' 3.96 m 
C-6' 62.7 CH2 H-6' 4.40, dd, J = 2.5, 11.8 
4.55, dd, J = 5.2, 11.8 
T h e ' T - N M R assignments agree with those reported in the literature.l].，] 
T h e unit of chemical shift and J-coupling constant are ppm and H z with respectively. 
dd = double doublet; ddd = double double doublet; m = multiplet; s = singlet; t = triplet 
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4.1.1.3 Identification of daucosterol 6'-stearate (3) 
Compound 3 was developed on a TLC plate with hexane:acetone (3:2) as the 
developing solvent. It showed no spots either under short or long wavelength U V 
lamp, while a pink spot was observed after spraying with concentrated sulfuric acid 
and heating. By putting the TLC plate into a chamber filled with iodine vapor, a 
yellowish orange spot was observed without spraying or heating. 
In the EIMS spectrum, the presence of signals at m/z 414 and 396 suggested that 
the compound contained a glycoside. 
Similar to compound 2, one anomeric carbon signal (d 101.8) together with 
hydroxylated carbons at 8 64.2 (CH2) and 571.0 (CH), 8 73.9 (CH), 5 74.3 (CH) 
and d 76.7 (CH) were displayed and indicated the presence of monosaccharide 
moiety. IR signals at 3385 cm"' (medium strong, broad peak), 1643 cm'' (weak, 
broad peak) and 1377 cm"' (medium, sharp peak) suggested the presence of hydroxyl 
group, double bond and ether linkage (-0-C0-CH-) respectively. Therefore, 
compound 3 should be a sterol skeleton containing a sugar part. Moreover, the IR 
peaks at 2920 cm'' and 2850 cm"' (strong, sharp peak) represented saturated -CH2 
and -CH3. It was also supported by the ^H- and '^C-NMR signals for methylene 
group at d h 1.25 and 5 c 29-30, as well as methyl group at 8 h 0.99 and (5 c 14. 
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Its IR spectrum further indicated the presence of an ester group, C0-C=0, 
(weak, broad peak at 1724 cm"'). The presence of an ester group explained the 
'^C-NMR signal at 5174.9. 
By comparison with literature values^ "^^ ,^ compound 3 was identified to be 
daucosterol 6丨-stearate. 
The N M R results of compound 3 are summarized in Table 4.3 and the structure 
of compound 3 was shown below, 
Et 
" " • ^ ^ i P r 
I 、、、\H 
H 
O H H 
\ ll u 
HO、、、,^Y^、〇H 
O H 
Fig 4.6 Structure of daucosterol 6'-stearate (3) 
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Table 4.3 'H- and ''C-NMR data of daucosterol 6'-stearate (3) 
i3c Chemical shift ((5) Multiplicity 'H Chemical shift ((5) 
C-1 37.8 CH2 H-1 0.92 m , 1.56 m 
C-2 30.3 CH2 H-2 2.29 m , 1.56 m 
C-3 80.3 C H H-3 3.51 m 
C-4 39.5 CH2 H-4 2.29 m 
C-5 140.8 C - -
C-6 122.6 C H H-6 5.34 s 
C-7 32.5 CH2 H-7 1.56 m , 1.98 m 
C-8 32.0 C H H-8 1.45m 
C-9 50.7 C H H-9 0.84 m 
C-10 37.2 C - -
C-11 21.6 CH2 H-11 1.46M 
C-12 40.3 CH2 H-12 1.98 m, 1.25 m 
C-13 42.8 C - -
C-14 57.3 C H H14 0.92 m 
C-15 24.8 CH2 H-1 5 0.9 m , 1.46 m 
C-16 28.8 CH2 H-16 1.25 m , 1.85 m 
C-17 56.7 C H H-17 1.25m 
C-18 12.4 CHs H-18 0.67 s 
C-19 19.9 C H B H-19 0.90 m 
C-20 36.7 C H H-20 1.46m 
C-21 19.3 CHs H-21 0.99 s 
47 
Table 4.1 (continued) 
C-22 34.5 C H 2 H-22 1.46m 
C-23 26.7 C H 2 H-23 1.25 m 
C-24 46.3 C H H-24 1.81m 
C-25 29.7 C H H-25 0.82 s 
C-26 19.5 CH3 H-26 0.84 s 
C-27 20.3 CH3 H-27 1.46m 
C-28 23.6 C H 2 H-28 0.87 s 
C-29 12.5 CH3 H-29 1.46m 
C - r 101.8 C H H - r 5.04 m 
C-2' 73.9 C H H-2' 4.08 m 
C-3’ 76.7 C H H-3' 4.31 m 
C-4' 71.0 C H H-4' 4.31m 
C-5' 74.3 C H H-5' 3.94 m 
C-6' 64.2 C H 2 H-6' 4.35 m 
C-r 174.9 C - -
C-2" 34.8 C H 2 H-2" 0.80 m 
C-3" 25.5 C H 2 H-3" 0.85 m 
C-4-16" 30.0-29.9 CH2 H-4-16" 1.25M 
C-17" 23.2 C H 2 H-17" 0.82111 
C-18" 14.6 CH3 H-18” 0.77 m 
T h e ' H - and ' ^ C - N M R assignments agree with those reported in the literature 
T h e unit of chemical shift is ppni 
m = multiplet; s = singlet 
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Figure 4.7 
Structures of Sterols 1-3 
28 g 
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Saponins are glycosides, consisting of a sugar moiety linked to a triterpene or 
steroid aglycone either by ether linkage or ester linkage. The structural variations 
of saponins lie in the attachment of different sugar groups to the aglycone part. 
Saponins possess a distinct physical property, i.e. surface activity, like soap. 
Most of the saponins show detergent properties, due to the hydrophobic 
aglycone and the hydrophilic sugar moiety. They form stable foams in water, show 
haemolytic activity, have a bitter taste, and are poisonous to fish. Saponins are 
conveniently defined on the basis of their molecular structures^two classes of 






sugar c h a i n ^ " - - ^ ^ steroid glycosides 
Fig. 4.8 Structure of triterpenes or steroid glycosides 
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4.1.2.1 Steroidal glycosides 
4.1.2.1.1 Identification of collettiside III (4) 
Compound 4 was developed on a TLC plate with chloroform:methanol (3:1) as 
the developing solvent. It showed no spots either under short or long wavelength 
U V lamp, while a pink single spot was observed after spraying with concentrated 
sulfuric acid and heating. By putting the TLC plate into a chamber filled with 
iodine vapor, a yellowish orange spot was observed without spraying or heating. 
The M S spectrum of compound 4 was obtained by the FAB mode. The 
quasi-molecular ions [M+Na]+ and [M+H]+ at m/z 891 and 869 were recorded, which 
were consistent with a molecular formula of C45H72O16. The fragment peaks 
resulting from the loss of sugar residues were found at m/z 111 (M+-rha), 575 
(M+-rha-rha) and 413 (M+-rlia-rha-glu). 
In the '^C-NMR spectrum, a total of 45 carbon signals were observed, including 
6 methyl, 11 methylene, 24 methine, and 4 quaternary carbons. Eighteen of these 
signals were readily ascribed to three monosaccharide groups (two rhamnose and one 
glucose), and the remaining 27 carbons were in good agreement with those of the 
structure of a steroid aglycone. 
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The IR spectrum showed the presence of hydroxyl group (strong, broad peak at 
3420 cm"'), double bond (weak, broad peak at 1636 cm"'), ether linkage (-0-C0-CH-, 
medium, sharp peak at 1383 cm"') and C-0 stretching (strong, broad peak at 
1047 cm-'). 
Inspection of the '^C-NMR spectra revealed three anomeric carbon signals at 
d 100.2, d 102.0 and d 102.8, which together with the M S fragmentation result, 
indicated that a trisaccharide sugar chain was present. 
By examining of the 'H-NMR spectra, together with the support of literature 
an olefinic proton at 6 5.62, as well as the anomeric protons of two 
rhamnose at 6 6.63 and (5 6.15, and that of a glucose at 6 4.62, were assigned. 
The structure of compound 4 was identified to be collettiside III, diosgenyl 
[a _L-i,hamnopyranosyl-(l —2)]-[ a -L-rhamnopyranosyl -(1—4)]- (3 -D-glycopyrano 
silde. A comparison of '^C-NMR data with the literature valiies[9-io] established the 
identity. 
The N M R results of compound 4 are summarized in Table 4.4. The structure 
of compound 4 is shown on p.59, Fig. 4.9. 
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Table 4.4 'H- and '^C-NMR data of collettiside III (4) 
Chemical shift ( 5) Multiplicity 'H Chemical shift ((5 ) 
C-1 37.5 CH2 H-1 1.61 o, 0.82 o 
C-2 30.1 CH2 H-2 2.04 m , 1.61 o 
C-3 78.1 C H H-3 3.78 m 
C-4 38.9 CH2 H-4 2.56 m, 
C-5 140.8 C - -
C-6 121.8 C H H-6 5.06 o 
C-7 31.8 CH2 H-7 1.84 0, 1.40 m 
C-8 31.6 C H H-8 1.49o 
C-9 50.3 C H H-9 0.82 o 
C-10 37.1 C - -
C-11 21.1 CH2 H-11 1.38 0 
C-12 39.8 CH2 H-12 1.61 o 
C-13 40.4 C - -
C-14 56.6 C H H14 0.93 o 
C-15 32.3 CH2 H-15 1.84 o, 0.30 m 
C-16 81.1 C H H-16 4.47 o 
C-17 62.8 C H H-17 1.61 o 
C-18 16.3 CHs H-18 0.61 o 
C-19 19.4 CH3 H-19 0.82 0 
C-20 41.9 C H H-20 1.84 0 
C-21 15.0 CH3 H-21 1.07m 
C-22 109.3 C - -
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Table 4.1 (continued) 
C-23 32.2 CH2 H-23 1.58 o 
C-24 29.2 CH2 H-24 1.53 0 
C-25 30.6 C H H-25 1.54 o 
C-26 66.8 CH2 H-26 3.43 m 
C-27 17.3 CH3 H-27 0.61 o 
102.8 C H H-r 4.62 0 
C-2' 78.5 C H H-2’ 4.15 0 
C-3' 76.8 C H H-3’ 4.18 0 
C-4’ 77.9 C H H-41 4.30 o 
77.9 C H H-5' 3.70 m 
61.2 CH2 H-6' 4.18 0 
C-1" 100.2 C H H-1" 6.15 s 
C-2" 72.5 C H H-2" 4.72 o 
C-3" 72.6 C H H-3" 4.47 0 
C-4" 73.8 C H H-4" 4.32 0 
C-5" 69.5 C H H-5" 5.06 0 
C-6" 18.5 CH3 H-6" 1.61 o 
C-l"| 102.0 C H H-1'" 6.63 0 
74.0 C H H-2”' 4.62 0 
C-3," 72.7 C H H-3'" 4.47 0 
C-4"’ 73.6 C H H-4"’ 4.32 0 
C-51" 70.4 C H H-5"’ 5.06 0 
C-6"丨 18.6 CH3 H-6"' 1.58 0 
Tlie ' H - and ' ' C - N M R assignments agree with those reported in the literature.⑴】 
T h e unit o f chemical shift is ppm, m = multiplet; 0 = overlapped 
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4.1.2.1.2 Identification of gracilline (5) 
Compound 5 was developed on a TLC plate with chloroform:methanol (3:1) as 
the developing solvent. It showed no spots either under short or long wavelength 
U V lamp, while a pink spot was observed after spraying with concentrated sulfuric 
acid and heating. By putting the TLC plate into a chamber filled with iodine vapor, 
a yellowish orange spot was observed without spraying or heating. 
The M S spectrum of compound 5 was obtained by the FAB mode. The 
qiiassi-moleciilar ion [M+H]+ m/z 885 was recorded, which is consistent with a 
molecular formula of C45H72O17. The fragmented peaks resulting from the loss of 
sugar residues were found at m/z 737 (M+-rha), 722 (M+-glu), 575 (M+-rha-glu) and 
413 (M^ -rha-glii-glu). 
The '^C-NMR spectra revealed that compound 5 was composed of 5 methyl, 12 
methylene, 24 methine, and 4 quaternary carbons. Eighteen of these signals were 
readily ascribed to three monosaccharide groups (one rhamnose and two glucose), 
and the remaining 27 carbons were in good agreement with those of the structure of a 
steroid aglycone. 
Inspection of the '^C-NMR spectra revealed three anomeric carbons signals at 
5 99.9, (5 102.1 and d 104.5, indicating a trisaccharide sugar chain was present. 
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The IR spectrum showed the presence of hydroxyl group (strong, broad peak at 
3420 cm''), double bond (weak, broad peak at 1633 cm''), ether linkage (-0-C0-CH-, 
medium, sharp peak at 1383 cm"') and C-0 stretching (strong, broad peak at 
1050 cm"'). 
According to the 'H-NMR spectra together with the support of literature data'"', 
an olefinic proton at 6 5.81, as well as the anomeric proton of rhamnose at 6 6.39 
and that of two glucose at d 4.68 and 6 5.81, were assigned. 
By comparison with literature data^ '^ '"', the structure of compound 5 was 
identified to be gracilline, diosgenyl [ a -L-rhamnopyranosyl-(l—2)]-[ JS 
-D-glucopyranosyl -(1 — 3)]- -D-glucopyranoside 
The N M R results of compound 5 are summarized in Table 4.5. The structure 
of compound 5 is shown on p.59, Fig 4.9. 
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Table 4.5 'H- and '^C-NMR data of gracilline (5) 
13C Chemical shift ((5) Multiplicity ^H Chemical shift ((5) 
C-1 37.1 CH2 H-1 1.61 o, 0.91 o 
C-2 29.2 CH2 H-2 2.12 O, 1.71 o 
C-3 78.3 C H H-3 3.86 m 
C-4 38.6 CH2 H-4 2.55 m 
C-5 140.7 C - -
C-6 121.8 C H H-6 5.81 o 
C-7 35.8 CH2 H-7 1.71 o, 1.45 o 
C-8 31.6 CH H-8 1.49O 
C-9 50.2 C H H-9 0.91 o 
C-10 37.4 C - -
C-11 21.1 CH2 H-11 1.34 0 
C-12 39.8 CH2 H-12 1.61 o 
C-13 40.7 C - -
C-14 56.6 C H H14 1.02 o 
C-15 35.8 CH2 H-15 1.95 O, 1.31 O 
C-16 81.1 C H H-16 4.34 0 
C-17 62.8 C H H-17 1.71 o 
C-18 16.3 CH3 H-18 0.64 s 
C-19 19.4 CH3 H-19 0.83 s 
C-20 41.9 C H H-20 1.85 0 
C-21 15.0 CH3 H-21 1.02 0 
C-22 109.3 C - -
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Table 4.1 (continued) 
C-23 32.2 C H 2 H-23 1.58 o 
C-24 29.9 C H 2 H-24 1.49 o 
C-25 30.5 C H H-25 1.52 o 
C-26 66.8 C H 2 H-26 3.50 o 
C-27 17.3 CH3 H-27 0.61 0 
C - r 99.9 CH H - r 4 .680 
C -2 ' 77.7 C H H -2 ' 4 . 1 9 0 
C-31 89.2 C H H-3' 4.15 0 
C-41 69.6 C H H-4' 4.01 o 
C-5' 77.7 C H H-5' 3.77 m 
C-6’ 62.3 C H 2 H-6' 4.86 o, 4.23 o 
C-1" 102.1 CH H-r 5.81 
C-2" 72.6 C H H-2" 4.87 0 
C-3" 72.4 C H H-3" 4.68 0 
C-4" 74.0 C H H-4" 4.23 0 
C-5" 69.6 C H 2 H-5" 4.87 0 
C-6" 18.6 CH3 H-6" 1.71 0 
C-r" 104.5 CH H - r 6.39 0 
C-2'" 74.9 C H H-2'" 3.98 0 
C-3", 77.1 C H H-3"’ 4.11 0 
C-41" 71.4 C H H-4'" 4.01 0 
C-5", 77.1 C H H-5丨"3.98 o 
C-6"' 62.3 C H 2 H-6'" 4.68 0,4.23 0 
T h e ' H - and ' ^ C - N M R assignments agree with those reported in the l iterature."…"� 
T h e unit o f chemical shift is ppm, m = multiplet; o = overlapped 
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Figure 4.9 
Structures of Saponin 4 and 5 
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Terpenoids are widely distributed in nature. They may be regarded as 
derivatives of oligomers of isoprene units joined head to tail. 
H X 
3 \ 
H 广 C-" 2 
2 H 
Fig. 4.10 Structure of isoprene 






The triterpenes are widely distributed in the plant and animal kingdoms, where 
they occur either in the free state, as ester, or as glycosides. They may be classified 
into three groups: (1) acyclic; (2) tetracyclic; and (3) pentacyclic. Representative 
structures are shown below: 
n r S ^ r ^ ^ ^ 
^ J rcooH 
I • 
Acyclic: Squalene Tetracyclic: Cyclolaudinol Pentacyclic: Ursolic acid 
Fig 4.11 Examples of Triterpenes 
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4.1.3.1 Identification of ^ -amyrin (6) 
Compound 6 was developed on a TLC plate with chloroform:acetone (50:1) as 
the developing solvent. It showed no spots either under short or long wavelength 
U V lamp, while a single pale pink spot was observed after spraying with 
concentrated sulfuric acid and heating. By putting the TLC plate into a chamber 
filled with iodine vapor, a yellowish orange spot was observed without spraying or 
heating. 
The F A B M S spectrum displayed a molecular ion peak [M+H]+ at m/z 427. 
Together with the '^C-NMR and DEPT data, the formula of compound 6 was 
deduced to be C30H50O. Therefore a triterpenoid structure was indicated. 
The IR spectrum indicated the presence of a hydroxyl group (medium strong, 
broad peak at 3413 cm"'). An 'H-NMR signal at 5 3.23, and a C H signal at 
6 c 79.6 in the D E P T spectrum suggested that the hydroxyl group was a secondary 
O H . , 
The IR spectrum indicated the presence of a double bond (weak peak at 
1647 cm''). N o absorption above 235 nni showed the absence of conjugated 
chromphore. The 'H-NMR spectrum also showed a proton signal of 
-CH=C- at (55.17. 
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The formula, together with the presence of O H and C=C, indicated that the 
molecule was a pentacyclic unsaturated triterpene alcohol. 
Also shown in the (H-NMR spectrum were eight singlet tertiary methyl signals 
at 5 0.76, (5 0.79, (5 0.83, 50.87, 50.93, 50.96, 5 0.99, 51.07 (total of24H). 
The presence of eight tertiary methyl protons indicated that the carbon skeleton was 
an oleanane or rearranged oleanane. 
A search in the literature indicated that the above spectral data were consistent 
with those of - a m y r i n T h e identity was established by co-TLC with an 
authentic reference compound. 
The N M R results of compound 6 are summarized in Table 4.6. The structure 
of compound 6 is shown on p.65, Fig. 4.12. 
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Table 4.6 '^C-NMR data of ^-amyrin (6) 
13c Chemical shift (<5 , ppm) Multiplicity 
C-l 39.1 CH2 
C-2 27.7 CH2 
C-3 79.6 C H 
C-4 40.3 C 
C-5 55.7 C H 
C-6 18.9 C H 2 
C-l 33.2 CH2 
C-8 39.3 C 
C-9 48.2 C H 
C-10 37.5 C 
C-11 24.1 CH2 
C-12 122.3 C H 
C-13 145.7 C 
C-14 42.2 C 
C-15 26.5 CH2 
C-16 27.5 CH2 
C-17 33.0 C 
C-18 47.8 C H 
C-19 47.4 CH2 
C-20 33.2 C 
C-21 35.3 CH2 
C-22 37.7 CH2 
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Table 4.6 (continued) 
C-23 29.3 CHs 
C-24 16.0 CHs 
C-25 16.1 CHs 
C-26 17.3 CH3 
C-27 26.7 CHs 
C-28 28.9 CH3 
C-29 33.9 CH3 
C-30 24.2 CHs 
T h e ' ' C - N M R assignments agree with those reported in the literature."""'''^ 
m = multiplet; 0 = overlapped 
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Figure 4.12 
Structure of /5 -amyrin 6 
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Lignans, long known as natural products, are distributed widely in plant 
kingdom. More than 200 compounds in this general class have been identified and 
a great diversity in the chemical assembly of the two characteristic phenylpropanoid 
units, as well as the degree of oxidation, and the types of substituents is apparent. 
< Q ~ c - c - c — 
Fig. 4.13 Structure of phenylpropanoid unit 
Lignans are dimers of phenylpropanoid (C6-C3) units linked by the central 
carbons of their side chain. Naturally occurring dimers that exhibit linkages other 
than this type of linkages are known as neolignans and are more limited in number 
and phylogenetic distribution. 
According to the way in which oxygen is incorporated into the skeleton, four 
structural groups of linear lignans can be recognized: lignans, or derivatives of 
butane (A); lignanolides, or derivatives of butanolide (B); monoepoxylignans, or 
derivatives of tetrahydrofuran (C) and bisepoxylignans, or derivatives of 
3,7-dioxabicyclo(3,3,0)octane (D). Further cyclization resulting from the 
introduction of a C-7/C-6" linkage allows the formation of a large class of 
compounds collectively known as cyclolignans. These occur either as 
tetrahydronaphthalene (E) or naphthalene (F) derivatives. Their structures are 
shown in Fig. 4.14. 
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— c c c c c c — 
( A ) ( B ) ( C ) ( D ) 
(E) (F) 
Fig. 4.14 Structure of linear lignans (A-D) and cyclolignans (E-F) derivatives 
OH 
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(b) Pinoresinol 
Fig. 4.15 Examples of lignans 
Many lignans are used as antioxidants, and others as insecticides. The essential 
feature of the biosynthesis of lignans is the oxidative coupling.[i】 
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4.1.4.1 Identification of (-)-sesamin (7) 
Compound 7 was developed on a TLC plate with chloroform:acetone (20:1) as 
the developing solvent. It showed a dark spot under short wavelength U V lamp and 
after spraying with concentrated sulfuric acid and heating. By putting the TLC 
plate into a chamber filled with iodine vapor, a yellow spot was observed. 
The EIMS spectrum displayed a molecular ion peak at m/z 354, corresponding 
to a formula C20H18O6. Its '^C-NMR spectrum showed ten carbon signal peaks 
indicating that this compound has a symmetric structure. In '^C-NMR spectrum, 
the presence of aromatic carbon signals at d 147.4, d 146.5, d 134.4, 5 118.7, d 
107.6 and d 105.9, together with other three carbon signals at (5 85.2, (571.1 and 
5 55.7 pointed to the structure of a lignan. The remaining carbon signal at 
8 100.5 indicated the presence of a O-CH2-O group. 
In the IR spectrum, the presence of aromatic group (weak, broad peak at 
1616 cm'' and strong, sharp peak at 1495 cm"') and C-0 stretching (medium, sharp 
peak at 1367 cm'', medium, sharp peak at 1196 cm"' and strong, sharp peak at 
1046 cm"') provided further support to the spectroscopic information of N M R . In 
addition, a strong, sharp peak at 1255 cm"' is typical for O-CH2-O. Its 'H-NMR 
spectrum also showed a mutliplet of aromatic protons between d 6.84-6.75. 
The presence of benzene ring (conjugated double bond) explained the strong 
U V absorption near 235 nm. An increasing number of substituents, O-CH2-O in 
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this case, shifted the long wave absorption to a lower wavelength, thus the presence 
of absorption at about 280 nm explained this shift. 
The special rotation of compound 7 was determined as -35 in chloroform. 
Further investigation of the EIMS of compound 7 and comparison with literature 
values[丨 5-18j, led to the identification as (-)-sesamin. 
The N M R results of compound 7 are summarized in Tables 4.7 and 4.8. The 
structure of compound 7 is shown on p.74, Fig. 4.16. 
4.1.4.2 Identification of (-)-epieudesmin (8) 
Compound 8 was developed on a TLC plate with chloroform:acetone (20:1) as 
the developing solvent. It showed a dark spot under short wavelength U V lamp and 
after spraying with concentrated sulfuric acid and heating. By putting the TLC 
plate into a chamber filled with iodine vapor, a yellow spot was observed. 
The EIMS spectrum displayed a molecular ion peak at m/z 386, corresponding 
to a formula C22H26O6. Its '^C-NMR spectrum showed eighteen carbon signals, the 
presence of the eleven aromatic carbon signals between d 149.7 and d 109.5, 
together with other six carbon signals between d 88.2 and S 50.7 pointed to the 
structure of a lignan. The remaining carbon signal at 5 56.4 indicated the presence 
of methoxy group. 
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Ill the IR spectrum, the presence of aromatic group (weak, sharp peak at 
1606 cm"' and medium, sharp peak at 1590 cm"') and C-0 stretching (medium, sharp 
peak at 1163 cm'' and 1039 cm'') provided supporting evidence to the spectroscopic 
information of N M R . In addition, a strong sharp peak at 1279 cm'' is typical for 
OCH3. Its 'H-NMR spectrum also showed a mutliplet of aromatic protons between 
(5 6.94-6.82. 
The presence of benzene ring (conjugated double bond) and the number of 
substitiients to it explained the strong absorption near 235 nm and 280 nm. The 
special rotation was measured as -101 in chloroform. Compound 8 was then 
identified to be (-)-epieduesmin by comparison of its spectroscopic properties with 
reported literature values.' 
The N M R results of compound 8 are summarized in Tables 4.7 and 4.8. The 
structure of compound 8 is shown on p.75, Fig. 4.17. 
4.1.4.3 Identification of (+)-methyl piperitol (9) 
Compound 9 was developed on a TLC plate with chloroform:acetone (20:1) as 
the developing solvent. It showed a dark spot under short wavelength U V lamp and 
after spraying with concentrated sulfuric acid and heating. By putting the TLC 
plate into a chamber filled with iodine vapor, a yellow spot was observed. 
The EIMS spectrum displayed a molecular ion peak at m/z 370, corresponding 
to a formula C21H22O6. By comparing with compounds 7 and 8, compound 9 was 
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also a lignan structure, while the presence of carbon signals at 5 101.6 and d 56.5 
indicated the presence of O-CH2-O and OCH3 groups. 
The special rotation was determined as +61 in chloroform. By comparison of 
the spectral information with literature dataj'^ "'^ ^ the identity of (+)-methyl piperitol 
was established. 
The N M R results of compound 9 are summarized in Tables 4.7 and 4.8. The 
structure of compound 9 is shown on p.74, Fig. 4.16. 
4.1.4.4 Identification of methyl pluviatilol (10) 
Compound 10 was developed on a TLC plate with hexane:acetone (1:1) as the 
developing solvent. It showed a dark spot under short wavelength U V lamp and 
after spraying with concentrated sulfuric acid and heating. By putting the TLC 
plate into a chamber filled with iodine vapor, a yellow spot was observed. 
The EIMS spectrum displayed a molecular ion peak at m/z 370, corresponding 
to a formula C21H22O6. By comparing with compounds 7 and 8, compound 10 was 
shown to possess a lignan skeleton, and the presence of carbon signals at d 101.5 
and d 56.5 indicated the presence of O-CH2-O and OCH3 groups. 
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The special rotation was measured as +78 in chloroform. Further investigation 
of the EIMS of compound 10 and comparison with literature valuesj^ "^'^ ^ led to the 
identification as methyl pluviatilol. 
The N M R results of compound 10 are summarized in Tables 4.7 and 4.8. The 
structure of compound 10 is shown on p.75, Fig. 4.17. 
4.1.4.5 Identification of (+)-syringaresinol (11) 
Compound 11 was developed on a TLC plate with hexane:acetone (1:1) as the 
developing solvent. It showed a dark spot under short wavelength U V lamp, and 
observed after spraying with concentrated sulfuric acid and heating. By putting the 
T L C plate into a chamber with iodine vapor, a yellow spot was observed. 
The C I M S exhibited a molecular ion peak at m/z 419 [M+H+]，corresponding to 
a molecular formula C22H26O8. A fragmentation at m/z 401 showed the loss of 
water. The IR spectrum revealed the presence of a hydroxy group at 3420 cm'' 
(medium, broad), benzene ring at 1517 cm"' (medium, sharp), methoxy group at 
1216 (strong, sharp), and C-O-C group at 1115 cm'' (strong, sharp). 
The U V spectrum of 11 also showed strong absorptions at 274 n m and 217 11m, 
supporting the assignment of benzene ring and the substitutents (OMe) that caused 
the shift of absorption. 
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The '^C-NMR spectrum of compound 11 displayed four aromatic ring carbons 
at 6 147.5, 6 134.7, d 132.5, d 103.1 indicating that the compound was highly 
symmetric. The special rotation was measured as +35 in chloroform. Compound 
11 was then identified to be (+)-syringaresinol by careful comparison of its 
spectroscopic properties with the reported literature valuesJ'^ "'^ ^ 
The N M R results of compound 11 are summarized in Tables 4.7 and 4.8. The 
structure of compound 11 is shown on p.74, Fig. 4.16. 
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Figure 4.16 
Structures ofLignans 7, 9 and 11 
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Figure 4.17 
Structure of Lignans 8 and 10 
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Table 4.7 ' H - N M R data of Lignans (7 — 11) 
Chemical shift ( 6, ppm) 
'H 7 8 9 10 11 
C-1, C-5 3.05 (m, 2H) 3.34 (m, IH) 3.09 (d, 2H) 2.91 (m, IH) 3.09 (s, 2H) 
2.94(111, IH) 3.33 (m,lH) 
C-2, C-6 4.72 (d, 2H) 4.89 (d, IH) 4.74 (d, 2H) 4.43 (d, IH) 4.74 (s, 2H) 
4.47 (d, IH) 4.85 (d, IH) 
C-4，C-8 4.24 (dd, 2H) 4.12 (m, IH) 4.27 (dd, 2H) 4.13 (dd, 2H) 3.872 — 3.91 
3.88 (dd, 2H) 3.86 (m, 2H) 3.88 (dd, 2H) 3.83 (dd, 2H) (o, 2H) 
3.34 (m, IH) 4.27 (s, 2H) 
aromatic 6.76-6.85 6.83 -6.94 6.77-6.90 6.80-6.93 6.59 (s, 4H) 
(m, 6H) (m, 6H) (m, 6H) (m, 6H) 
-OCH2O- 5.95 (s, 2H) - 5.95 (s, 2H) 5.96 (s, 2H) -
OCH3 - 3.88-3.91 3.90,3.89 3.90,3.88 3.91 (o, 4Me) 
(0, 4Me) (s, 2Me) (s, 2Me) 
O H - - - - 5.54 (s, 2H) 
T h e ' H - N M R assignments agree with those reported in the l i t e r a t u r e . " ' 8 � 
dd = double doublet; m = multiplet; 0 = overlap; s = singlet 
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Table 4.8 '"C-NMR data of Lignans (7 - 11) 
Chemical shift ( d , ppm) 
丨 3C 7 8 9 10 11 
C-1 53.7 50.6 54.9 50.7 54.7 
C-2 85.2 82.5 86.4 82.6 86.5 
C-4 71.1 71.5 72.2 71.4 72.2 
C-5 53.7 55.0 54.7 55.1 54.7 
C-6 85.2 88.1 86.3 88.1 86.5 
C-8 71.1 70.2 72.3 70.2 72.2 
C-r 134.4 131.4 134.0'" 132.8' 132.5 
C-2. 105.9b 109.4。 107.0"- 106.9k 103.1 
C-3 丨 146.5' 148.5^ 147.6'^  147.1丨 147.5 
C-4' 147.4a 149.3d 149.2'^  149.3 丨 134.7 
C-5’ 107.6b 110.5。 109.7= \09.7^ 147.5 
C-6’ 118.7 118.2' 118.8' 119.0'" 103.1 
C - r 134.1 134.1 135.61� 134.1' 132.5 
C-2" 105.9b 109.6' 108.7^ 108.7k 103.1 
C-3" 146.5' 149.2^ 148.5'^  148.2' 147.5 
C-4" 147.4' 149.7d 149.7'^  149.7' 134.7 
C-5" 107.6B 110.5C 111.6- 111.5K 147.5 
C-6" 118.7 119.0' 119.9' 119.2'" 103.1 
OCH2O 100.5 - 101.6 101.5 -
O M e - 56.4 56.5 56.5 56.8 
T h e ' ^ C - N M R assignments agree with those reported in the literature.''^''^^ 
Assignments will the same superscript (a-m) are interchangeable. 
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4.1.5 Alkanol 
4.1.5.1 Identification of 1-octacosanol (12) 
Compound 12 was developed on a TLC plate with chloroform:acetone (50:1) as 
the developing solvent. It showed no spot under both short and long wavelength 
U V lamp, while a light brown spot was observed after spraying with concentrated 
sulfuric acid and heating. 
In the IR spectrum, it showed the presence of hydroxy group (medium, broad 
peak at 3403 cm"') and -CH2 and -CH3 groups (strong, broad peak at 2926 cm"', 
medium, broad peak at 1457 cm'' and medium, broad peak at 1377 cm''). In the 
'H-NMR spectrum, a triplet at 6 3.57 indicated that hydroxy group was present. In 
addition, the '^C-NMR and D E P T spectrum showed evidence that the hydroxy group 
was a primary one. 
In the EIMS spectrum, the presence of a molecular ion at m/z 410 suggested a 
formula C28H58O. A fragmentation at m/z 392 indicated the loss of water. The 
presence ion at m/z 364, 336, 308, 280, 252, etc., were in good agreement with the 
successive loss of ethylene (C2H4+)，and the presence of m/z 57 as the base peak was 
due to C4H9. 
By comparing with literature values^compound 12 was identified to be 
1 -octacosanol. The structure of compound 12 is shown on p.80, Fig. 4.18. 
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4.1.5.2 Identification of methyl tetracosanoate (13) 
Compound 13 was developed on a TLC plate with hexane:acetone (2:1) as the 
developing solvent. It showed no spot under both long and short wavelength U V 
lamp, while a light brown spot was observed after spraying with concentrated 
sulfuric acid and heating. 
In the '^C-NMR spectrum, the presence of a carbon signal at d 179.8 indicated 
the presence of a carbonyl group in the compound. The IR spectrum showed the 
presence of carbonyl group (strong, sharp peak at 1707 cm"') and -CH2 and -CH3 
groups (strong, sharp peak at 2918 cm\ strong, sharp peak at 1466 cm"' and medium, 
sharp peak at 724 cm"'). Together with the simplicity of 'H-NMR, '^C-NMR and 
DEPT spectra, the compound was suggested to be a straight chain alkane bearing a 
carbonyl group. 
Ill the CIMS spectrum, the presence of a quasi-molecular ion at m/z 411 [M+H+] 
indicated the formula of compound 13 to be C27H54O2. The fragment ions at m/z 
383，355, 327, 299, 271, etc., were in good agreement with the successive loss of 
ethylene (C2H4+) and C = 0 group. The presence of peak at m/z 257 (271-14) and 
239 (257-18) indicated the loss of CH2+ and H2O; and the base peak at m/z 57 was 
due to C4H9. 
The identity of compound 13 was established by comparison with reported 
spectral data'''^ "^ ^^^ of methyl tetrasocanoate. The structure of compound 12 is shown 
on p.80. Fig. 4.18. 
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Figure 4.18 
Structure of Alkanol and its derivatives 12-13 
26 / \ 3 1 
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26 24 \ /i7 4 2 U 
Methyl tetracosanoate (13) 
80 
4.2 Conclusion 
An alcoholic extract of Zanthoxylum acanthopodium, a herb used in Chinese 
medicine, were purified by repeated chromatography (including normal phase and 
reverse phase, as well as macro-reticular resinous adsorption chromatography) to 
afford thirteen organic chemical compounds. Each compound was subjected to 
spectroscopic analysis in order to establish its chemical structure. Substantial 
structural evidence was obtained from N M R spectroscopic data as well as mass 
spectrometry. The chemical and physical properties were determined by thin layer 
chromatography, infrared spectrometry, ultra-violet spectrometry，optical rotation and 
melting point determination. 
The identities of the isolated compounds are summarized in Table 4.9 and four 
of these were reported for the first time from Z acanthopodium. According to the 
literatures, some of them were found to have bioactivity. 
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Table 4.9 
Compounds isolated from Zanthoxylum acanthopodium 
Compound Name Extract Page* 
1 P-Sitosterol hexane-ethyl acetate 37 
2 P-Sitosterol-p-D-glucoside (Daucosterol) hexane-ethyl acetate 42 
3 Daucosterol 6'-stearate hexane-ethyl acetate 46 
4 Collettiside III butanol 59 
5 Gracilline butanol 59 
6 P-Amyrin hexane-ethyl acetate 65 
7 (-)-Sesamin hexane-ethyl acetate 74 
8 (-)-Epieudesmin hexane-ethyl acetate 75 
9 (+)-Methyl piperitol hexane-ethyl acetate 74 
10 Methyl pluviatilol hexane-ethyl acetate 75 
11 (+)-Syringaresinol hexane-ethyl acetate 74 
12 1 -Octacosanol hexane-ethyl acetate 80 
13 Methyl hexacosanoate hexane-ethyl acetate 80 
* where the structure of the compound is shown. 
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Appendix 1.1 
'H-NMR spectrum of /3 -sitosterol 
I V ^ 
——.一―—L^― 
/ \ A A /n ^ 
= g ° ? |S| |™| laf 
a o 01 r u '"T ( \ j o 
c “ o f\i oj oi o) 
— — m 
I • ' I r -j - r - r - i - T r r r - i - r - p - r r - t — r - t—t _ • • | _ | • ' | ' | ' ' » i - . - r - t - i - r — . 
p p m 7 6 5 4 3 3 1 ‘ 
Appendix 11 
'H-NMR spectrum of ^ -sitosterol 
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Appendix 7.1 
'H-NMR spectrum of methyl piperitol 
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Appendix 12 
D E P T spectrum of methyl piperitol 
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Appendix 7.3 
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Appendix 7.4 
U V spectrum of methyl piperitol 
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'H-NMR spectrum of 1- octacosanol 
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Appendix 8.2 
'^C-NMR spectrum of 1- octacosanol 
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Appendix 9.1 
1 H - N M R spectrum of methyl hexacosanoate 
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Appendix 9.2 
I3C-NMR spectrum of methyl hexacosanoate 
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